These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 17064663

  • 1. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase.
    Zuo Y, Shields SK, Chakraborty C.
    Biochem Biophys Res Commun; 2006 Dec 15; 351(2):361-7. PubMed ID: 17064663
    [Abstract] [Full Text] [Related]

  • 2. Cdc42 negatively regulates intrinsic migration of highly aggressive breast cancer cells.
    Zuo Y, Wu Y, Chakraborty C.
    J Cell Physiol; 2012 Apr 15; 227(4):1399-407. PubMed ID: 21618528
    [Abstract] [Full Text] [Related]

  • 3. Prostaglandin E2-mediated migration of human trophoblast requires RAC1 and CDC42.
    Nicola C, Lala PK, Chakraborty C.
    Biol Reprod; 2008 Jun 15; 78(6):976-82. PubMed ID: 18235104
    [Abstract] [Full Text] [Related]

  • 4. Positive regulation of migration and invasion by vasodilator-stimulated phosphoprotein via Rac1 pathway in human breast cancer cells.
    Han G, Fan B, Zhang Y, Zhou X, Wang Y, Dong H, Wei Y, Sun S, Hu M, Zhang J, Wei L.
    Oncol Rep; 2008 Oct 15; 20(4):929-39. PubMed ID: 18813837
    [Abstract] [Full Text] [Related]

  • 5. Maspin controls mammary tumor cell migration through inhibiting Rac1 and Cdc42, but not the RhoA GTPase.
    Shi HY, Stafford LJ, Liu Z, Liu M, Zhang M.
    Cell Motil Cytoskeleton; 2007 May 15; 64(5):338-46. PubMed ID: 17301947
    [Abstract] [Full Text] [Related]

  • 6. Overexpression of Rac1 in leukemia patients and its role in leukemia cell migration and growth.
    Wang J, Rao Q, Wang M, Wei H, Xing H, Liu H, Wang Y, Tang K, Peng L, Tian Z, Wang J.
    Biochem Biophys Res Commun; 2009 Sep 04; 386(4):769-74. PubMed ID: 19563775
    [Abstract] [Full Text] [Related]

  • 7. The Na+-H+ exchanger-1 induces cytoskeletal changes involving reciprocal RhoA and Rac1 signaling, resulting in motility and invasion in MDA-MB-435 cells.
    Paradiso A, Cardone RA, Bellizzi A, Bagorda A, Guerra L, Tommasino M, Casavola V, Reshkin SJ.
    Breast Cancer Res; 2004 Sep 04; 6(6):R616-28. PubMed ID: 15535843
    [Abstract] [Full Text] [Related]

  • 8. Activation of H-Ras and Rac1 correlates with epidermal growth factor-induced invasion in Hs578T and MDA-MB-231 breast carcinoma cells.
    Koh MS, Moon A.
    Biochem Biophys Res Commun; 2011 Mar 04; 406(1):25-9. PubMed ID: 21281602
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Involvement of Rac and Rho signaling in cancer cell motility in 3D substrates.
    Yamazaki D, Kurisu S, Takenawa T.
    Oncogene; 2009 Apr 02; 28(13):1570-83. PubMed ID: 19234490
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
    Lewis-Saravalli S, Campbell S, Claing A.
    Cell Signal; 2013 Sep 02; 25(9):1813-9. PubMed ID: 23707487
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of transendothelial migration and invasion of human breast cancer cells by preventing geranylgeranylation of Rho.
    Kusama T, Mukai M, Tatsuta M, Nakamura H, Inoue M.
    Int J Oncol; 2006 Jul 02; 29(1):217-23. PubMed ID: 16773203
    [Abstract] [Full Text] [Related]

  • 14. PED interacts with Rac1 and regulates cell migration/invasion processes in human non-small cell lung cancer cells.
    Zanca C, Cozzolino F, Quintavalle C, Di Costanzo S, Ricci-Vitiani L, Santoriello M, Monti M, Pucci P, Condorelli G.
    J Cell Physiol; 2010 Oct 02; 225(1):63-72. PubMed ID: 20648624
    [Abstract] [Full Text] [Related]

  • 15. Radixin regulates cell migration and cell-cell adhesion through Rac1.
    Valderrama F, Thevapala S, Ridley AJ.
    J Cell Sci; 2012 Jul 15; 125(Pt 14):3310-9. PubMed ID: 22467863
    [Abstract] [Full Text] [Related]

  • 16. Roles of the Rac1 and Rac3 GTPases in human tumor cell invasion.
    Chan AY, Coniglio SJ, Chuang YY, Michaelson D, Knaus UG, Philips MR, Symons M.
    Oncogene; 2005 Nov 24; 24(53):7821-9. PubMed ID: 16027728
    [Abstract] [Full Text] [Related]

  • 17. Rab35 is required for Wnt5a/Dvl2-induced Rac1 activation and cell migration in MCF-7 breast cancer cells.
    Zhu Y, Shen T, Liu J, Zheng J, Zhang Y, Xu R, Sun C, Du J, Chen Y, Gu L.
    Cell Signal; 2013 May 24; 25(5):1075-85. PubMed ID: 23353182
    [Abstract] [Full Text] [Related]

  • 18. Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
    Patel V, Rosenfeldt HM, Lyons R, Servitja JM, Bustelo XR, Siroff M, Gutkind JS.
    Carcinogenesis; 2007 Jun 24; 28(6):1145-52. PubMed ID: 17234718
    [Abstract] [Full Text] [Related]

  • 19. Green tea (-)-epigallocatechin-3-gallate down-regulates VASP expression and inhibits breast cancer cell migration and invasion by attenuating Rac1 activity.
    Zhang Y, Han G, Fan B, Zhou Y, Zhou X, Wei L, Zhang J.
    Eur J Pharmacol; 2009 Mar 15; 606(1-3):172-9. PubMed ID: 19171136
    [Abstract] [Full Text] [Related]

  • 20. Reduced expression of insulin-like growth factor I receptors in MCF-7 breast cancer cells leads to a more metastatic phenotype.
    Pennisi PA, Barr V, Nunez NP, Stannard B, Le Roith D.
    Cancer Res; 2002 Nov 15; 62(22):6529-37. PubMed ID: 12438247
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.